Lsd1 ablation triggers metabolic reprogramming of brown adipose tissue
Duteil, DelphineUrologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Germany
Tosic, MilicaUrologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Germany
Lausecker, FranziskaUrologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Germany
Nenseth, Hatice Z.Urologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Germany
Müller, Judith M.Urologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Germany
Urban, SylviaUrologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Germany
Willmann, DominicaUrologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Germany
Petroll, KerstinUrologische Klinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Germany - Center for Biological Systems Analysis, Freiburg, Germany
Messaddeq, NadiaIGBMC, Department of Functional Genomics and Cancer, Université de Strasbourg, Illkirch, France
Arrigoni, LauraMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Manke, ThomasMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
English
Previous work indicated that lysine-specific demethylase 1 (Lsd1) can positively regulate the oxidative and thermogenic capacities of white and beige adipocytes. Here we investigate the role of Lsd1 in brown adipose tissue (BAT) and find that BAT- selective Lsd1 ablation induces a shift from oxidative to glycolytic metabolism. This shift is associated with downregulation of BAT-specific and upregulation of white adipose tissue (WAT)-selective gene expression. This results in the accumulation of di- and triacylglycerides and culminates in a profound whitening of BAT in aged Lsd1- deficient mice. Further studies show that Lsd1 maintains BAT properties via a dual role. It activates BAT-selective gene expression in concert with the transcription factor Nrf1 and represses WAT-selective genes through recruitment of the CoREST complex. In conclusion, our data uncover Lsd1 as a key regulator of gene expression and metabolic function in BAT.